Shop

RIPEX 400 (Fast-Acting)
June 14, 2016
GIGATEST
June 16, 2016
Show all

INFERNO (HELIOS) YOHIMBINE AND CLENBUTEROL BLEND

$25.00$1,715.00

Inferno combines the thermogenic properties of Clenbuterol and Yohimbine into a targeted local area fat loss product. By injecting Inferno into the subcutaneous lipid (fat) area, the bioavailability of both blends is transmitted at 100% into the problem area basically melts the fat away. Dosages range from 0.1ml to 2ml for each injection site, 6hours apart each day. Alternating site injection areas every 6 hours allows for an even distribution of Inferno and therefore an even fat loss pattern is produced.

Mechanism of action of Clenbuterol

Yohimbe, and its subset yohimbine, are fat-burning compounds, primarily used to lose fat during short term fasting. Yohimbine is also an aphrodisiac and can aid erectile dysfunction.

Mechanism of action of Clenbuterol

Clenbuterol is a 2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug. It causes an increase in aerobic capacity, central nervous system stimulation, and an increase in blood pressure and oxygen transportation. It increases the rate at which body fat is metabolized while increasing the bodys BMR. It is commonly used for smooth muscle relaxant properties. This means that it is a bronchodilator and tocolytic with pronounced fat loss properties

Bulk oil orders (250ml and 500ml) are packed in sterile aluminium canisters.

Clear
SKU: N/A Category:
EACH ML CONTAINS:
Clenbuterol
40mcg
Yohimbine 5mg
Benzyl Alcohol 2%

Dosage and administration:

Half life 36 hours (Clenbuterol) 2.5 hours (Yohimbine)

Adult dose (Male) 0.25ml to 2ml split into multiple injections for subcutaneous injection into higher body fat, problem areas

Adult dose (Femal) 0.10ml to 1ml split into multiple injections for subcutaneous injection into higher body fat, problem areas

Average Cycle Length: Follow either a 5 day on 2 day off protocol for higher dosing regimes or 6-8weeks cycles for low dose regimes

Anabolic #: NA
Androgenic #: NA

Bioavailability: Estimated at 100%

CAS Name:17-hydroxy-yohimban-16-carboxylic acid methyl ester

CAS Name: RS-1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol

Reviews

There are no reviews yet.

Be the first to review “INFERNO (HELIOS) YOHIMBINE AND CLENBUTEROL BLEND”

Contraindications

Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.

Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant.

Adverse reactions

Genitourinary System – In males:

a. Prepubertal: Phallic enlargement and increased frequency of erections.
b. Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability. Increased or decreased libido.

You may also like…